Low-flow, low-gradient aortic stenosis: dobutamine stress decisions
A 78-year-old man with NYHA class III symptoms has LVEF 32%. Rest echo: LVOT diameter 2.2 cm, LVOT VTI 16 cm, aortic valve VTI 44 cm, peak velocity 2.6 m/s, mean gradient 22 mmHg, AVA 0.8 cm², stroke volume index 28 mL/m². Low-dose dobutamine infusion increases heart rate from 78 to 92 bpm; LVOT VTI rises to 20 cm, aortic VTI to 84 cm, mean gradient to 30 mmHg, AVA to 0.9 cm², and EF to 38%. Ejection time is 300 ms at rest and 280 ms at peak. The patient's blood pressure is stable.
1. Calculate the dimensionless index and stroke volume. How do you classify the stenosis at rest?
Read the worked answer
LVOT CSA = π × (1.1 cm)² = 3.80 cm². Stroke volume = 3.80 × 16 cm = 60.8 mL. Ejection time 300 ms gives flow rate Q = 60.8/0.300 = 203 mL/s; this is low (normal around 250 mL/s). Dimensionless index = LVOT VTI/AV VTI = 16/44 = 0.36.
At rest: AVA 0.8 cm², mean gradient 22 mmHg, DVI 0.36, SVI 28 mL/m², EF 32%. This is low-flow, low-gradient AS. The DVI of 0.36 falls in the moderate range (0.25-0.50) rather than the severe range (<0.25), so the area and gradient do not prove true-severe AS; pseudo-severe AS is possible because low flow can make the gradient and calculated area misleading. Dobutamine is appropriate.
2. Interpret the dobutamine response: is there contractile reserve? Is the stenosis true-severe or pseudo-severe? Calculate projected AVA at a normal flow rate of 250 mL/s.
Read the worked answer
Contractile reserve: SV increases from 60.8 to 76.0 mL (25%), and EF from 32% to 38% (absolute 6 points, relative 19%). This is contractile reserve by the SV criterion, though the EF change is borderline by a 20% relative criterion.
Peak stress flow: SV = 3.80 × 20 = 76.0 mL; Q = 76.0/0.280 = 271 mL/s. AVA at stress = 76.0/84 = 0.90 cm². Projected AVA at a normal flow of 250 mL/s = 0.8 + (0.9 − 0.8) × (250 − 203)/(271 − 203) = 0.8 + 0.1 × 0.69 = 0.87 cm². Because projected AVA remains below 1.0 cm², the stenosis behaves as true-severe rather than pseudo-severe. If AVA had increased above 1.0 cm² with flow, pseudo-severe AS would be favored.
3. What are the pitfalls of this dobutamine study, and how would you integrate the result into management?
Read the worked answer
Pitfalls include measurement error in the LVOT diameter (squared in the continuity equation), angle error in LVOT or AV VTI, use of a single beat in irregular rhythm, and the assumption that flow and area change linearly for the projected AVA. Dobutamine can cause arrhythmia, ischemia, or hypotension, so the study must be monitored. Contractile reserve definitions vary; a 25% SV increase is meaningful, but a 6-point EF increase is modest. Management: true-severe AS with contractile reserve and symptoms generally warrants consideration of AVR/TAVR by the heart team. If there were no contractile reserve, operative risk is high and palliation or balloon aortic valvuloplasty may be considered. If pseudo-severe, treat the cardiomyopathy and reassess.